AstraZeneca
oncology highlights acquisition furthers our position in car and shorter manufacturing time increased manufacturing capacity lower cell dose required may improve safety enhanced cell fitness potential to improve outcomes strengthening portfolio and pipeline | AstraZeneca
Company
Deck Type
Deck date
February 2024
Slide
18 of 45
Other recent decks by AstraZeneca
Results
February 2025
Results
November 2024
Results
November 2024
Investor Event
September 2024
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2024 Slidebook.io